Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29911919
Publication Date : //

Innovative treatment for pes cavovarus: a pilot study of 13 children.


Background and purpose - Pes cavovarus (PCV) is a complex deformity, frequently related to neurological conditions and associated with foot pain, callosities, and walking instability. The deformity has the tendency to increase during growth. Orthotic treatment is ineffective and surgery may be troublesome. We present the preliminary results of a new mini-invasive surgical technique for correction of this foot deformity. Patients and methods - We operated on 13 children (24 feet), age 7-13 years. In 7 children the deformity was neurological in origin. The surgical technique included a dorsal hemiepiphysiodesis of the 1st metatarsal, and a plantar fascia release. The clinical deformity, hindfoot flexibility, and foot callosities, together with a radiological assessment (Meary angle, calcaneal pitch, and talo-calcaneal angle), was done pre- and postoperatively. At final check-up, after a median of 28 months (12-40), the Oxford Ankle Foot Questionnaire for children (OXAFQ-C) was used to assess patient satisfaction. The primary outcome was the hindfoot varus correction. Results - All the operated feet improved clinically and radiologically. Heel varus improved from a mean 6° preoperatively to 5° valgus postoperatively. In those children where treatment was initiated at a younger age, full correction was achieved. Footwear always improved. Interpretation - This treatment may offer a less aggressive alternative in the treatment of PCV in young children and may eventually reduce the amount of surgery needed in the future.

Authors : Sanpera Ignacio , Frontera-Juan Guillem , Sanpera-Iglesias Julia , Corominas-Frances Laura ,

Related products :

Catalog number Product name Quantity
PROTSYN009 Mammalian Pilot Study
PROTSYN011 Baculovirus Pilot Study
PROTSYN007 E.Coli Pilot Expression Study
PROTSYN008 E.Coli Pilot Study with TAG REMOVAL
PROTSYN010 Mammalian Pilot Study with Tag-removal (includes 100 ml transient expression, purification, & tag-removal)
EIAAB12627 Early growth response protein 3,EGR3,EGR-3,Homo sapiens,Human,PILOT,Zinc finger protein pilot
MD80001 MagCustom Feasibility Study, Bead development on client demand in small scale as feasability study 1 item
31-224-01 MORSE A 17 mm, B 22 mm, C 160 mm for children
31-226-01 MORSE A 17 mm, B 22 mm, C 160 mm for children ALUMINIUM
31-144-01 DOYEN FOR CHILDREN RIGHT 15.5 cm,6,1/4" x 20
31-224-01 MORSE A 17 mm, B 22 mm, C 160 mm for children x10
31-140-01 DOYEN FOR CHILDREN RIGHT 17 cm, 6,3/4" x 20
31-140-01 DOYEN FOR CHILDREN RIGHT x10
31-144-01 DOYEN FOR CHILDREN RIGHT x10
31-178-01 FINOCCHIETTO INFANT A 15 mm, B 15 mm, C 75 mm FOR CHILDREN x10
31-144-02 DOYEN FOR CHILDREN LEFT x10
31-140-02 DOYEN FOR CHILDREN LEFT x10
31-144-02 DOYEN FOR CHILDREN LEFT 15.5 cm,6,1/4" x 20
31-178-01 FINOCCHIETTO INFANT A 15 mm, B 15 mm, C 75 mm FOR CHILDREN x 2
31-140-02 DOYEN FOR CHILDREN LEFT 17 cm, 6,3/4" x 20
31-180-01 FINOCCHIETTO INFANT A 15 mm, B 15 mm, C 75 mm ALUMINIUM FOR CHILDREN x 2
31-180-01 FINOCCHIETTO INFANT A 15 mm, B 15 mm, C 75 mm ALUMINIUM FOR CHILDREN x10
03-114-20 MAGILL tongue holding forceps for children 20 cm,8" x 20
03-114-20 MAGILL tongue holding forceps for children 20 cm,8" x10
SC00A8-100 SC00A8-100, Fluorescein Labeled Human Chondrocytes-Pilot, 100,000 Cells.


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur